Discover
TVGN
Tevogen Bio Holdings Inc.
7.81
2 x 4.83
2 x 8.30
bid
ask
+
0.10
1.30%
2 @ 05:27 PM
7.04 -0.77 (9.86%)
| Ytd | -52.81% | |
| 1y | -81.00% |
7.43
day range
7.81
3.89
52 week range
41.75
| Open | 7.43 | Prev Close | 7.71 | Low | 7.43 | High | 7.81 | Mkt Cap | 50.86M |
| Vol | 20.47K | Avg Vol | 13.97K | EPS | -6.29 | P/E | N/A | Forward P/E | N/A |
| Beta | -1.03 | Short Ratio | 0.09 | Inst. Own | 3.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 6.31 | 200-d Avg | 10.10 | 1yr Est | 4.20 |
| Income Statement | |||
| Operating Expenses | 5.66M | ||
| Research and Development Expense | 3.28M | ||
| Selling, General and Administrative Expense | 2.38M | ||
| Operating Income | -5.66M | ||
| Interest Expense | 98.39K | ||
| Net Income | -5.84M | ||
| Net Income Common Stock | -5.84M | ||
| Net Income Common Stock (USD) | -5.84M | ||
| Consolidated Income | -5.76M | ||
| Net Income to Non-Controlling Interests | 77.84K | ||
| Earnings per Basic Share | -1.52 | ||
| Earnings per Basic Share (USD) | -1.52 | ||
| Earnings per Diluted Share | -1.52 | ||
| Earning Before Interest & Taxes (EBIT) | -5.74M | ||
| Earning Before Interest & Taxes (USD) | -5.74M | ||
| Weighted Average Shares | 3.83M | ||
| Weighted Average Shares Diluted | 3.83M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.08M | ||
| Cash and Equivalents (USD) | 1.08M | ||
| Trade and Non-Trade Receivables | 158.82K | ||
| Current Assets | 2.01M | ||
| Property, Plant & Equipment Net | 1.47M | ||
| Total Assets | 4.73M | ||
| Debt Current | 1.98M | ||
| Total Debt | 9.44M | ||
| Current Liabilities | 6.15M | ||
| Debt Non-Current | 7.46M | ||
| Total Liabilities | 13.62M | ||
| Accumulated Retained Earnings (Deficit) | -150.87M | ||
| Shareholders Equity | -8.89M | ||
| Shareholders Equity (USD) | -8.89M | ||
| Assets Non-Current | 2.72M | ||
| Total Debt (USD) | 9.44M | ||
| Liabilities Non-Current | 7.47M | ||
| Trade and Non-Trade Payables | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 60.14K | ||
| Net Cash Flow from Financing | 3.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 389.85K | ||
| Issuance (Purchase) of Equity Shares | 428.25K | ||
| Net Cash Flow from Operations | -3.01M | ||
| Share Based Compensation | 3.29M | ||